Problems with the report of the Expert Panel on blood cholesterol levels in children and adolescents.
An Expert Panel convened by the National Cholesterol Education Program has recommended selective screening and treatment of children for high blood cholesterol levels, based on family history of cardiovascular disease or high blood cholesterol. This recommendation is problematic for several reasons. First, the recommended diets are likely to cause only a slight decrease in low-density lipoprotein cholesterol levels, the projected benefits of which will be offset by a similar decrease in high-density lipoprotein cholesterol levels. Lack of efficacy of the recommended diets could lead to use of more restrictive diets or to cholesterol lowering drugs. Second, even under optimistic assumptions, beneficial effects of cholesterol intervention will be small and delayed for many decades. As a result, childhood cholesterol-lowering efforts will not be cost-effective. Third, the Expert Panel's recommendations do not address important gender differences. Girls have higher average cholesterol levels than boys. They will therefore qualify for more dietary and drug treatment despite their lower age-adjusted risk of heart disease and the lack of association between cholesterol levels and cardiovascular mortality in women. Finally, recent evidence from randomized trials, cohort studies, and animal experiments suggests that cholesterol lowering may have serious adverse effects. This evidence was not discussed in the Expert Panel's report. Given current evidence, any screening and treatment of children for high blood cholesterol levels is, at best, premature.
Department of Laboratory Medicine, School of Medicine, University of California-San Francisco.
T B
TB
Newman
A M
AM
Garber
N A
NA
Holtzman
S B
SB
Hulley
D000293:Adolescent; D001161:Arteriosclerosis / Q000517:prevention & control*; D002648:Child; D002675:Child, Preschool; D002784:Cholesterol / Q000097:blood*; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000453:epidemiology / Q000517:prevention & control; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000175:diagnosis / Q000178:diet therapy* / Q000188:drug therapy; D008297:Male; D008403:Mass Screening / Q000191:economics; D015201:Meta-Analysis as Topic; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D012737:Sex Factors
D002784:Cholesterol